Scarica l'app Stockscreener
47.05
3.93%
1.78
Pre-mercato:
47.09
0.04
+0.09%
Avidity Biosciences Inc Azioni (RNA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
144.56%
3.847
|
1.573 | 2.336 | 2.045 | 3.543 |
Operating Expenses
|
31.48%
174.99
|
133.09 | 100.47 | 84.67 | 80.73 |
| Benefits Costs and Expenses |
100.00%
-
|
117.35 | - | - | 72.40 |
| Costs And Expenses |
49.12%
174.99
|
117.35 | 100.47 | 84.67 | 72.40 |
| Operating Income/Loss |
30.13%
-171.14
|
-131.52 | -98.13 | -82.63 | -77.19 |
| Nonoperating Income/Loss |
12.18%
13.83
|
15.74 | 17.74 | 11.83 | 8.332 |
| Income/Loss From Continuing Operations Before Tax |
103.32%
3.847
|
-115.77 | 2.336 | -70.79 | -68.86 |
| Income/Loss From Continuing Operations After Tax |
35.88%
-157.31
|
-115.77 | -80.40 | -70.79 | -68.86 |
|
Net Income/Loss
|
35.88%
-157.31
|
-115.77 | -80.40 | -70.79 | -68.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.30%
129.62
|
129.23 | 123.38 | 106.93 | 87.21 |
| Diluted Average Shares |
0.30%
129.62
|
129.23 | 123.38 | 106.93 | 87.21 |
| Basic Earnings Per Share |
34.44%
-1.21
|
-0.90 | -0.65 | -0.65 | -0.79 |
| Diluted Earnings Per Share |
34.44%
-1.21
|
-0.90 | -0.65 | -0.65 | -0.79 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):